Acquiring Company
IMCD N.V
Acquired Company
Cobapharma
BarcelonaManufacturingBiotechnologyFood and BeverageChemical ManufacturingManufacturingBiotechnologyPharmaceuticalDescription
IMCD Spain, a leading distributor of specialty chemicals and ingredients, has finalized the acquisition of Cobapharma, S.L.U, a European distributor in the pharmaceutical and nutraceutical industry. This strategic acquisition aims to expand IMCD's offerings, enhance its portfolio of high-quality APIs and nutraceutical ingredients, and reach a broader customer base.
Quick answer
IMCD N.V is acquiring Cobapharma, announced April 24, 2024.
- How much did IMCD N.V pay for Cobapharma?
- The deal value was not disclosed.
- What does IMCD N.V do?
- IMCD N.V. is a global leading distribution partner and formulator of specialty chemicals and ingredients.
- Where are IMCD N.V and Cobapharma based?
- Cobapharma is based in Barcelona, Catalonia, Spain.
- Who are the decision-makers at IMCD N.V?
- Fundz holds 5 contacts at IMCD N.V. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Food and Beverage and Chemical Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- LCI completes acquisition of certain assets of Pfizer Pakistan Limited and Pfizer Inc. to enhance pharmaceutical portfolio (May 20, 2024)
- Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity (April 22, 2024)
- Future Pak proposes acquisition of Vanda Pharmaceuticals for $7.25 to $7.75 per share in cash (April 17, 2024)
- CoreRx, Inc. completes acquisition of Societal CDMO, Inc. to enhance drug formulation and manufacturing capabilities (April 8, 2024)
- ProMed Pharma LLC acquires SpineThera's Manufacturing Capabilities and an Option to License Intellectual Property (April 3, 2024)
Who to call at IMCD N.V, and when
When IMCD N.V changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day IMCD N.V raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IMCD N.V, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IMCD N.V. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment IMCD N.V makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Cobapharma?
Cobapharma was acquired by IMCD N.V. The deal was reported on April 24, 2024. IMCD N.V. is a global leading distribution partner and formulator of specialty chemicals and ingredients. IMCD N.V is privately held and operates in Manufacturing.
When did IMCD N.V acquire Cobapharma?
IMCD N.V's acquisition of Cobapharma was reported on April 24, 2024. IMCD Spain, a leading distributor of specialty chemicals and ingredients, has finalized the acquisition of Cobapharma, S.L.U, a European distributor in the pharmaceutical and nutraceutical industry. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cobapharma do?
COBAPHARMA is a pharmaceutical company with focus on international business development and marketing of API, Finished Dosage Form and advanced intermediates for the pharmaceutical and biotech industry. It is privately held, operating in Manufacturing, and is based in Barcelona.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.